Skip to content

Peter R. Brzechffa, M.D.

NPI 1497869184ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· New York, NY

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in New York, New York, licensed in NY, with an NPI issued in August 2006. Part D covered 12 prescriptions written in 2024, 92% of them generic. Ferring Pharmaceuticals Inc. reported $27.81 in payments in 2025, mostly food and beverage.

Overview

NPI1497869184
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedAug 18, 2006
Last updated in NPPESMar 4, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Obstetrics/Gynecology (NY)

Part D prescriptions in 2024

Prescriptions (claims)12 · 18 30-day fills
Total drug cost$30.23
Generic share92% of claims

Medicare sources and data years

Education and affiliations

Graduation year1990
Medicare specialtyObstetrics/Gynecology

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$27.81 · 1 payment from 1 company
  • 2024$77.59 · 3 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$27.811

What the 2025 payments were for

  • Food and Beverage$27.81 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in New York

All 153 Obstetrics & Gynecology, Reproductive Endocrinology providers in New York · All Obstetrics & Gynecology, Reproductive Endocrinology providers in New York